{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:22Z","timestamp":1792791442579,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1038\/leu.2016.149","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T09:46:36Z","timestamp":1464083196000},"page":"2322-2331","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":139,"title":["Cryptic splicing events in the iron transporter ABCB7 and other key target genes in SF3B1-mutant myelodysplastic syndromes"],"prefix":"10.1038","volume":"30","author":[{"given":"H","family":"Dolatshad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pellagatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F G","family":"Liberante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Llorian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Repapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Steeples","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Scifo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R N","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B H","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Killick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ku\u0161ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K I","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K I","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C W J","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Boultwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"key":"BFleu2016149_CR1","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1056\/NEJM199905273402107","volume":"340","author":"ML Heaney","year":"1999","unstructured":"Heaney ML, Golde DW . Myelodysplasia. N Engl J Med 1999; 340: 1649\u20131660.","journal-title":"N Engl J Med"},{"key":"BFleu2016149_CR2","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1056\/NEJMoa1103283","volume":"365","author":"E Papaemmanuil","year":"2011","unstructured":"Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, Bowen D et al. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 2011; 365: 1384\u20131395.","journal-title":"N Engl J Med"},{"key":"BFleu2016149_CR3","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/nature10496","volume":"478","author":"K Yoshida","year":"2011","unstructured":"Yoshida K, Sanada M, Shiraishi Y, Nowak D, Nagata Y, Yamamoto R et al. Frequent pathway mutations of splicing machinery in myelodysplasia. Nature 2011; 478: 64\u201369.","journal-title":"Nature"},{"key":"BFleu2016149_CR4","doi-asserted-by":"publisher","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","volume":"122","author":"E Papaemmanuil","year":"2013","unstructured":"Papaemmanuil E, Gerstung M, Malcovati L, Tauro S, Gundem G, Van Loo P et al. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 2013; 122: 3616\u20133627, quiz 3699.","journal-title":"Blood"},{"key":"BFleu2016149_CR5","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.1182\/blood-2011-09-377275","volume":"118","author":"L Malcovati","year":"2011","unstructured":"Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, Pascutto C et al. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic\/myeloproliferative neoplasms. Blood 2011; 118: 6239\u20136246.","journal-title":"Blood"},{"key":"BFleu2016149_CR6","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1182\/blood-2011-12-399337","volume":"119","author":"F Thol","year":"2012","unstructured":"Thol F, Kade S, Schlarmann C, Loffeld P, Morgan M, Krauter J et al. Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes. Blood 2012; 119: 3578\u20133584.","journal-title":"Blood"},{"key":"BFleu2016149_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1182\/blood-2015-03-633537","volume":"126","author":"L Malcovati","year":"2015","unstructured":"Malcovati L, Karimi M, Papaemmanuil E, Ambaglio I, Jadersten M, Jansson M et al. SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts. Blood 2015; 126: 233\u2013241.","journal-title":"Blood"},{"key":"BFleu2016149_CR8","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM et al. The 2016 revision to the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia. Blood 2016; 127: 2391\u20132405.","journal-title":"Blood"},{"key":"BFleu2016149_CR9","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1182\/blood-2002-07-2006","volume":"101","author":"M Cazzola","year":"2003","unstructured":"Cazzola M, Invernizzi R, Bergamaschi G, Levi S, Corsi B, Travaglino E et al. Mitochondrial ferritin expression in erythroid cells from patients with sideroblastic anemia. Blood 2003; 101: 1996\u20132000.","journal-title":"Blood"},{"key":"BFleu2016149_CR10","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood-2012-05-430876","volume":"120","author":"V Visconte","year":"2012","unstructured":"Visconte V, Rogers HJ, Singh J, Barnard J, Bupathi M, Traina F et al. SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes. Blood 2012; 120: 3173\u20133186.","journal-title":"Blood"},{"key":"BFleu2016149_CR11","doi-asserted-by":"publisher","first-page":"e1970","DOI":"10.1371\/journal.pone.0001970","volume":"3","author":"J Boultwood","year":"2008","unstructured":"Boultwood J, Pellagatti A, Nikpour M, Pushkaran B, Fidler C, Cattan H et al. The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts. PLoS One 2008; 3: e1970.","journal-title":"PLoS One"},{"key":"BFleu2016149_CR12","doi-asserted-by":"publisher","first-page":"3567","DOI":"10.1182\/blood-2006-04-015768","volume":"109","author":"C Pondarre","year":"2007","unstructured":"Pondarre C, Campagna DR, Antiochos B, Sikorski L, Mulhern H, Fleming MD . Abcb7, the gene responsible for X-linked sideroblastic anemia with ataxia, is essential for hematopoiesis. Blood 2007; 109: 3567\u20133569.","journal-title":"Blood"},{"key":"BFleu2016149_CR13","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1182\/blood-2006-08-041632","volume":"109","author":"P Cavadini","year":"2007","unstructured":"Cavadini P, Biasiotto G, Poli M, Levi S, Verardi R, Zanella I et al. RNA silencing of the mitochondrial ABCB7 transporter in HeLa cells causes an iron-deficient phenotype with mitochondrial iron overload. Blood 2007; 109: 3552\u20133559.","journal-title":"Blood"},{"key":"BFleu2016149_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1261\/rna.2224411","volume":"17","author":"MJ Schellenberg","year":"2011","unstructured":"Schellenberg MJ, Dul EL, MacMillan AM . Structural model of the p14\/SF3b155. branch duplex complex. RNA 2011; 17: 155\u2013165.","journal-title":"RNA"},{"key":"BFleu2016149_CR15","doi-asserted-by":"publisher","first-page":"4752","DOI":"10.1128\/MCB.18.8.4752","volume":"18","author":"O Gozani","year":"1998","unstructured":"Gozani O, Potashkin J, Reed R . A potential role for U2AF-SAP 155 interactions in recruiting U2 snRNP to the branch site. Mol Cell Biol 1998; 18: 4752\u20134760.","journal-title":"Mol Cell Biol"},{"key":"BFleu2016149_CR16","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1101\/gad.12.10.1409","volume":"12","author":"C Wang","year":"1998","unstructured":"Wang C, Chua K, Seghezzi W, Lees E, Gozani O, Reed R . Phosphorylation of spliceosomal protein SAP 155 coupled with splicing catalysis. Genes Dev 1998; 12: 1409\u20131414.","journal-title":"Genes Dev"},{"key":"BFleu2016149_CR17","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1261\/rna.2030510","volume":"16","author":"RM Lardelli","year":"2010","unstructured":"Lardelli RM, Thompson JX, Yates JR 3rd, Stevens SW . Release of SF3 from the intron branchpoint activates the first step of pre-mRNA splicing. RNA 2010; 16: 516\u2013528.","journal-title":"RNA"},{"key":"BFleu2016149_CR18","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1182\/blood-2011-12-399774","volume":"119","author":"H Makishima","year":"2012","unstructured":"Makishima H, Visconte V, Sakaguchi H, Jankowska AM, Abu Kar S, Jerez A et al. Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis. Blood 2012; 119: 3203\u20133210.","journal-title":"Blood"},{"key":"BFleu2016149_CR19","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/leu.2014.170","volume":"29","author":"V Visconte","year":"2015","unstructured":"Visconte V, Avishai N, Mahfouz R, Tabarroki A, Cowen J, Sharghi-Moshtaghin R et al. Distinct iron architecture in SF3B1-mutant myelodysplastic syndrome patients is linked to an SLC25A37 splice variant with a retained intron. Leukemia 2015; 29: 188\u2013195.","journal-title":"Leukemia"},{"key":"BFleu2016149_CR20","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/leu.2014.331","volume":"29","author":"H Dolatshad","year":"2015","unstructured":"Dolatshad H, Pellagatti A, Fernandez-Mercado M, Yip BH, Malcovati L, Attwood M et al. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells. Leukemia 2015; 29: 1092\u20131103.","journal-title":"Leukemia"},{"key":"BFleu2016149_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1101\/gr.152132.112","volume":"24","author":"PG Ferreira","year":"2014","unstructured":"Ferreira PG, Jares P, Rico D, Gomez-Lopez G, Martinez-Trillos A, Villamor N et al. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Res 2014; 24: 212\u2013226.","journal-title":"Genome Res"},{"key":"BFleu2016149_CR22","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/2159-8290.CD-13-0330","volume":"3","author":"SJ Furney","year":"2013","unstructured":"Furney SJ, Pedersen M, Gentien D, Dumont AG, Rapinat A, Desjardins L et al. SF3B1 mutations are associated with alternative splicing in uveal melanoma. Cancer Discov 2013; 3: 1122\u20131129.","journal-title":"Cancer Discov"},{"key":"BFleu2016149_CR23","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/path.4483","volume":"235","author":"SL Maguire","year":"2015","unstructured":"Maguire SL, Leonidou A, Wai P, Marchio C, Ng CK, Sapino A et al. SF3B1 mutations constitute a novel therapeutic target in breast cancer. J Pathol 2015; 235: 571\u2013580.","journal-title":"J Pathol"},{"key":"BFleu2016149_CR24","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/jnci\/djt257","volume":"105","author":"LM Scott","year":"2013","unstructured":"Scott LM, Rebel VI . Acquired mutations that affect pre-mRNA splicing in hematologic malignancies and solid tumors. J Natl Cancer Inst 2013; 105: 1540\u20131549.","journal-title":"J Natl Cancer Inst"},{"key":"BFleu2016149_CR25","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature11547","volume":"491","author":"AV Biankin","year":"2012","unstructured":"Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, Johns AL et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 2012; 491: 399\u2013405.","journal-title":"Nature"},{"key":"BFleu2016149_CR26","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ccr.2011.10.004","volume":"20","author":"O Abdel-Wahab","year":"2011","unstructured":"Abdel-Wahab O, Levine R . The spliceosome as an indicted conspirator in myeloid malignancies. Cancer Cell 2011; 20: 420\u2013423.","journal-title":"Cancer Cell"},{"key":"BFleu2016149_CR27","doi-asserted-by":"publisher","first-page":"3211","DOI":"10.1182\/blood-2011-12-400994","volume":"119","author":"F Damm","year":"2012","unstructured":"Damm F, Kosmider O, Gelsi-Boyer V, Renneville A, Carbuccia N, Hidalgo-Curtis C et al. Mutations affecting mRNA splicing define distinct clinical phenotypes and correlate with patient outcome in myelodysplastic syndromes. Blood 2012; 119: 3211\u20133218.","journal-title":"Blood"},{"key":"BFleu2016149_CR28","doi-asserted-by":"publisher","first-page":"e1004105","DOI":"10.1371\/journal.pcbi.1004105","volume":"11","author":"C DeBoever","year":"2015","unstructured":"DeBoever C, Ghia EM, Shepard PJ, Rassenti L, Barrett CL, Jepsen K et al. Transcriptome sequencing reveals potential mechanism of cryptic 3' splice site selection in SF3B1-mutated cancers. PLoS Comput Biol 2015; 11: e1004105.","journal-title":"PLoS Comput Biol"},{"key":"BFleu2016149_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 2013; 29: 15\u201321.","journal-title":"Bioinformatics"},{"key":"BFleu2016149_CR30","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics 2009; 25: 2078\u20132079.","journal-title":"Bioinformatics"},{"key":"BFleu2016149_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nbt.1621","volume":"28","author":"C Trapnell","year":"2010","unstructured":"Trapnell C, Williams BA, Pertea G, Mortazavi A, Kwan G, van Baren MJ et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 2010; 28: 511\u2013515.","journal-title":"Nat Biotechnol"},{"key":"BFleu2016149_CR32","doi-asserted-by":"publisher","first-page":"E5593","DOI":"10.1073\/pnas.1419161111","volume":"111","author":"S Shen","year":"2014","unstructured":"Shen S, Park JW, Lu ZX, Lin L, Henry MD, Wu YN et al. rMATS: robust and flexible detection of differential alternative splicing from replicate RNA-Seq data. Proc Natl Acad Sci USA 2014; 111: E5593\u2013E5601.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2016149_CR33","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/nmeth.1528","volume":"7","author":"Y Katz","year":"2010","unstructured":"Katz Y, Wang ET, Airoldi EM, Burge CB . Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 2010; 7: 1009\u20131015.","journal-title":"Nat Methods"},{"key":"BFleu2016149_CR34","doi-asserted-by":"publisher","first-page":"16127","DOI":"10.1073\/pnas.1311055110","volume":"110","author":"G Caceres","year":"2013","unstructured":"Caceres G, McGraw K, Yip BH, Pellagatti A, Johnson J, Zhang L et al. TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients. Proc Natl Acad Sci USA 2013; 110: 16127\u201316132.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2016149_CR35","doi-asserted-by":"publisher","first-page":"11406","DOI":"10.1073\/pnas.0610477104","volume":"104","author":"A Pellagatti","year":"2007","unstructured":"Pellagatti A, Jadersten M, Forsblom AM, Cattan H, Christensson B, Emanuelsson EK et al. Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients. Proc Natl Acad Sci USA 2007; 104: 11406\u201311411.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2016149_CR36","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1038\/ng1469","volume":"36","author":"M Hiller","year":"2004","unstructured":"Hiller M, Huse K, Szafranski K, Jahn N, Hampe J, Schreiber S et al. Widespread occurrence of alternative splicing at NAGNAG acceptors contributes to proteome plasticity. Nat Genet 2004; 36: 1255\u20131257.","journal-title":"Nat Genet"},{"key":"BFleu2016149_CR37","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1128\/MCB.13.8.4939","volume":"13","author":"CW Smith","year":"1993","unstructured":"Smith CW, Chu TT, Nadal-Ginard B . Scanning and competition between AGs are involved in 3' splice site selection in mammalian introns. Mol Cell Biol 1993; 13: 4939\u20134952.","journal-title":"Mol Cell Biol"},{"key":"BFleu2016149_CR38","doi-asserted-by":"publisher","first-page":"e1001016","DOI":"10.1371\/journal.pcbi.1001016","volume":"6","author":"A Corvelo","year":"2010","unstructured":"Corvelo A, Hallegger M, Smith CW, Eyras E . Genome-wide association between branch point properties and alternative splicing. PLoS Comput Biol 2010; 6: e1001016.","journal-title":"PLoS Comput Biol"},{"key":"BFleu2016149_CR39","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.celrep.2015.09.053","volume":"13","author":"RB Darman","year":"2015","unstructured":"Darman RB, Seiler M, Agrawal AA, Lim KH, Peng S, Aird D et al. Cancer-associated SF3B1 hotspot mutations induce cryptic 3' splice site selection through use of a different branch point. Cell Rep 2015; 13: 1033\u20131045.","journal-title":"Cell Rep"},{"key":"BFleu2016149_CR40","doi-asserted-by":"publisher","first-page":"10615","DOI":"10.1038\/ncomms10615","volume":"7","author":"S Alsafadi","year":"2016","unstructured":"Alsafadi S, Houy A, Battistella A, Popova T, Wassef M, Henry E et al. Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage. Nat Commun 2016; 7: 10615.","journal-title":"Nat Commun"},{"key":"BFleu2016149_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1073\/pnas.0136770100","volume":"100","author":"BP Lewis","year":"2003","unstructured":"Lewis BP, Green RE, Brenner SE . Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci USA 2003; 100: 189\u2013192.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2016149_CR42","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/S0092-8674(01)00475-5","volume":"106","author":"Y Ishigaki","year":"2001","unstructured":"Ishigaki Y, Li X, Serin G, Maquat LE . Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20. Cell 2001; 106: 607\u2013617.","journal-title":"Cell"},{"key":"BFleu2016149_CR43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2001-12-0188","volume":"100","author":"L Nilsson","year":"2002","unstructured":"Nilsson L, Astrand-Grundstrom I, Anderson K, Arvidsson I, Hokland P, Bryder D et al. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Blood 2002; 100: 259\u2013267.","journal-title":"Blood"},{"key":"BFleu2016149_CR44","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1016\/j.ccr.2014.03.036","volume":"25","author":"PS Woll","year":"2014","unstructured":"Woll PS, Kjallquist U, Chowdhury O, Doolittle H, Wedge DC, Thongjuea S et al. Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. Cancer Cell 2014; 25: 794\u2013808.","journal-title":"Cancer Cell"},{"key":"BFleu2016149_CR45","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1128\/MCB.21.5.1509-1514.2001","volume":"21","author":"K Chua","year":"2001","unstructured":"Chua K, Reed R . An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing. Mol Cell Biol 2001; 21: 1509\u20131514.","journal-title":"Mol Cell Biol"},{"key":"BFleu2016149_CR46","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1128\/MCB.21.6.1986-1996.2001","volume":"21","author":"LO Penalva","year":"2001","unstructured":"Penalva LO, Lallena MJ, Valcarcel J . Switch in 3' splice site recognition between exon definition and splicing catalysis is important for sex-lethal autoregulation. Mol Cell Biol 2001; 21: 1986\u20131996.","journal-title":"Mol Cell Biol"},{"key":"BFleu2016149_CR47","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1101\/gad.2014311","volume":"25","author":"A Corrionero","year":"2011","unstructured":"Corrionero A, Minana B, Valcarcel J . Reduced fidelity of branch point recognition and alternative splicing induced by the anti-tumor drug spliceostatin A. Genes Dev 2011; 25: 445\u2013459.","journal-title":"Genes Dev"},{"key":"BFleu2016149_CR48","doi-asserted-by":"crossref","unstructured":"Lee SC, Dvinge H, Kim E, Cho H, Micol JB, Chung YR et al. Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins. Nat Med e-pub ahead of print 2 May 2016.","DOI":"10.1038\/nm.4097"},{"key":"BFleu2016149_CR49","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1172\/JCI76979","volume":"124","author":"YY Yien","year":"2014","unstructured":"Yien YY, Robledo RF, Schultz IJ, Takahashi-Makise N, Gwynn B, Bauer DE et al. TMEM14C is required for erythroid mitochondrial heme metabolism. J Clin Invest 2014; 124: 4294\u20134304.","journal-title":"J Clin Invest"},{"key":"BFleu2016149_CR50","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1046\/j.1365-2141.2001.02581.x","volume":"112","author":"E Hellstr+om-Lindberg","year":"2001","unstructured":"Hellstr+om-Lindberg E, Schmidt-Mende J, Forsblom AM, Christensson B, Fadeel B, Zhivotovsky B . Apoptosis in refractory anaemia with ringed sideroblasts is initiated at the stem cell level and associated with increased activation of caspases. Br J Haematol 2001; 112: 714\u2013726.","journal-title":"Br J Haematol"},{"key":"BFleu2016149_CR51","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/bjh.13610","volume":"171","author":"S Conte","year":"2015","unstructured":"Conte S, Katayama S, Vesterlund L, Karimi M, Dimitriou M, Jansson M et al. Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts. Br J Haematol 2015; 171: 478\u2013490.","journal-title":"Br J Haematol"},{"key":"BFleu2016149_CR52","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s100380050051","volume":"43","author":"Y Shimada","year":"1998","unstructured":"Shimada Y, Okuno S, Kawai A, Shinomiya H, Saito A, Suzuki M et al. Cloning and chromosomal mapping of a novel ABC transporter gene (hABC7), a candidate for X-linked sideroblastic anemia with spinocerebellar ataxia. J Hum Genet 1998; 43: 115\u2013122.","journal-title":"J Hum Genet"},{"key":"BFleu2016149_CR53","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/S0014-5793(97)01414-2","volume":"418","author":"G Kispal","year":"1997","unstructured":"Kispal G, Csere P, Guiard B, Lill R . The ABC transporter Atm1p is required for mitochondrial iron homeostasis. FEBS Lett 1997; 418: 346\u2013350.","journal-title":"FEBS Lett"},{"key":"BFleu2016149_CR54","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/leu.2012.298","volume":"27","author":"M Nikpour","year":"2013","unstructured":"Nikpour M, Scharenberg C, Liu A, Conte S, Karimi M, Mortera-Blanco T et al. The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts. Leukemia 2013; 27: 889\u2013896.","journal-title":"Leukemia"},{"key":"BFleu2016149_CR55","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1038\/ncomms6901","volume":"6","author":"M Gerstung","year":"2015","unstructured":"Gerstung M, Pellagatti A, Malcovati L, Giagounidis A, Porta MG, Jadersten M et al. Combining gene mutation with gene expression data improves outcome prediction in myelodysplastic syndromes. Nat Commun 2015; 6: 5901.","journal-title":"Nat Commun"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2016149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2016149","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2016149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:05:35Z","timestamp":1684433135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2016149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["BFleu2016149"],"URL":"https:\/\/doi.org\/10.1038\/leu.2016.149","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]},"assertion":[{"value":"11 March 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}